Flosonics Medical: An Emerging Capability with Strategic Potential for Europe
33 pages · PDF · 16 September 2025 · Licensed single-user copy, watermarked to the buyer
€499 excl. VAT — EU VAT calculated at checkout (VAT ID accepted for reverse charge); invoice issued after payment
One click to Stripe — guest checkout, no account. Your download appears on the confirmation page and arrives by e-mail right after payment (link valid 72 hours, up to 5 downloads).
About this report
Flosonics Medical is a Canadian medtech innovator that has captured global attention with its first-of-kind wearable ultrasound device for hemodynamic monitoring. From its base in Northern Ontario, the company has engineered a wireless Doppler ultrasound patch that promises to transform how clinicians manage critical care scenarios.
The appeal of this technology stretches far beyond hospital wards – a portable, hands-free sensor that can continuously track blood flow opens new frontiers for emergency medicine on the battlefield and in disaster zones. In an era when Europe is prioritizing strategic autonomy in vital technologies, Flosonics stands out as a dual-use trailblazer.
Key questions this report answers
- What is Flosonics' core wearable wireless Doppler ultrasound patch for continuous hemodynamic monitoring?
- How mature is the technology, and how does its portable, hands-free sensing enable battlefield and disaster-zone dual use?
- How does Flosonics fit Europe's push for strategic autonomy in vital medical technologies, and what partnerships support market entry?
- What capability gaps and strategic indicators define its potential for Europe?
Inside this report
- Executive Summary
- 1. Corporate Identity & Legal Structure
- 2. Strategic Business Profile
- 3. Technology Portfolio Mapping
- 4. Technology Readiness Assessment
- 5. European Strategic Program Participation
- 6. Academic & Research Origins
- 7. Dual-Use Applications & European Market Strategy
- 8. Strategic Partnerships & European Industrial Alliances
- 9. European Market Focus & Operational Domains
- 10. Intellectual Property & European Innovation Assets
- 11. Leadership & European Technical Expertise
- 12. Capability and Gap Analysis
- 13. Strategic Indicators & European Innovation Metrics
Who it's for
Investors screening Flosonics Medical, competitors and partners assessing their position, and analysts who need a sourced, structured account of the entity and its technology.
Related reports
Methodology, format & delivery
DFM reports are built from primary and official sources — TED procurement notices, CORDIS and the EU Funding & Tenders Portal, EIB operations, the NATO Innovation Fund portfolio, SIPRI data, official budget documents and company disclosures — read together with the underlying legal texts. Sources are cited in the document; it reflects them as of its publication date (16 September 2025). You receive a 33-page PDF, watermarked to you on every page, delivered on the confirmation page and by e-mail immediately after checkout (personal link valid 72 hours, up to 5 downloads). Guest checkout, single-user licence — Terms of Sale.
Related on DFM
More Tactical reports · Military Medical Tech · Free summary of this report · All reports
Prefer unlimited access?
Prefer unlimited access? Every report like this is included in the DFM Analysis subscription. See plans →